INDUSTRY INSIGHTS YOUR PEERS ARE READING
Cabot Wealth Management Inc increased its stake in Gw Pharmaceuticals Plc (GWPH) by 34.2% The institutional investor held 20,865 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $3.60M, up from 15,548 at the end of the previous reported quarter. MORE
for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis. MORE
Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. ICC International Cannabis Corp. CSE: WRLD.U)(FWB: MORE
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S. MORE
TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. MORE
Life-threatening side effects from pharmaceuticals led one man to try cannabis. In this testimonial, he shares how cannabis helped him overcome refractory lockjaw and severe nerve pain MORE
CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co., MORE
Press Release: Thailand Government Pharmaceutical Organization. Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee. Dr. Vitoon Danwiboon, Director of the Pharmaceutical Organization. MORE
Forbes report. MORE
Europe Cannabis and Pain Management Devices on Cancer Pain market by key players: Cannabis Players: GW Pharmaceuticals. UNIMED PHARMACEUTICALS. Valeant Pharmaceuticals. MORE
can refocus its regulatory approach to pharmaceuticals, adapted from the one used in Europe, to better connect the value prescription drugs provide and their price. Cannabis Medical Marijuana News RX Affordable Care Act Donald Trump drugs FDA Germany health care opioids pharmaceuticals MORE
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S. MORE
Conventional pharmaceuticals commonly used to treat pain sometimes have a negative impact on the immune system, GI tract, liver, and kidneys. MORE
Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. Cannabis Medical Marijuana News opioids pharmaceuticals MORE
Has the American Epilepsy Society (AES) published a position statement on the use of CBD for the treatment of seizures? Yes, the AES has. MORE
8, 2019 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC | CTTH) announced […]. MORE
In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy. MORE
Cannabis Science Decriminalization Legalization Medical Marijuana 411 Politics Prohibition Addiction Opioids PharmaceuticalAmerica is in the throes of a major crisis. Opioid addiction has taken over many parts of the country and is taking a number of lives daily. The opioid crisis is at its breaking point right now. More people are spending time in hospitals or losing their lives to opioid overdose than ever before. According to the National Institute on Read Article. MORE
study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. are moving away from alcohol and pharmaceuticals in favour of cannabis use. The post New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S. A new U.S. MORE
The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain. MORE
This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. Another example of cannabinoid mono therapy is the THC pharmaceutical Marinol. MORE
Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. MORE
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. MORE
MEDICAL CANNABIS PHARMACEUTICALSTwo Health and Wellness Powerhouses Collaborate to Help Those Suffering from Seizures Through an Innovative and Fast-Acting Intranasal Spray Solution. CHICAGO – July 11, 2019 / Canna Newswire / – Nature’s Grace and Wellness & JC Pharma, Inc. MORE
GW Pharmaceuticals has been creating unusual blends of clinical cannabis for over two decades. Blog Featured Health Marijuana News Science Technology abnormal cbd CBD Epidiolex ethanol gpr GW Pharmaceuticals synthetic cbd MORE
Medicinal cannabis was legalised in portugal in June 2018 by Parliament, however only one cannabis-based medication is legal in Portugal; Sativex, produced by British firm GW Pharmaceuticals. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor. MORE
Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc. MORE
Alternative Medicine cannabis education industry Logical Fallacies medical marijuana medicine News Pharmaceuticals Science-Based Medicine Skepticism about cbd dr. roman fake placebo skeptic skeptical skepticism thc truthIt's not easy gathering my wits and going public about this. MORE
CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co., MORE
There have been calls to loosen regulations around medical cannabis to increase access for those who need it, but the government must resist and view cannabis with the same scrutiny as any other new medicine. Read all at ( paywall) [link]. Medical Cannabis News MORE
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S. MORE
Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. MORE
To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. About Zhejiang Yatai Pharmaceutical Co., Zhejiang Yatai Pharmaceutical Co., MORE
Here’s the press release. The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research. MORE
Cannabis Featured Medical Marijuana News autism CBD oil Epilepsy GW Pharmaceuticals Sanjay GuptaLeading marijuana researchers now believe a cannabis compound could treat autism symptoms. MORE
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. MORE
Pharmaceutical Related Topics 
The Fresh Toast
MARCH 20, 2019
Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. Cannabis Medical Marijuana News opioids pharmaceuticals
Cannabis Law Report
SEPTEMBER 24, 2019
Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. About GW Pharmaceuticals plc and Greenwich Biosciences, Inc.
Cannabis Law Report
NOVEMBER 10, 2019
Europe Cannabis and Pain Management Devices on Cancer Pain market by key players: Cannabis Players: GW Pharmaceuticals. UNIMED PHARMACEUTICALS. Valeant Pharmaceuticals.
Cannabis Life Network
OCTOBER 8, 2019
8, 2019 /CNW/ – Aurora Cannabis Inc. (“Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, and CTT Pharmaceutical Holdings, Inc., (“CTT”) (OTC | CTTH) announced […].
Cannabis Law Report
JULY 23, 2019
TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC.
Canna Newswire
MAY 21, 2019
To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. About Zhejiang Yatai Pharmaceutical Co., Zhejiang Yatai Pharmaceutical Co.,
|
Canna Newswire
MAY 30, 2019
CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,
Cannabis Law Report
JULY 12, 2019
This differs sharply from the conventional course of cannabis medicine, which is to use whole, clean plant extracts to treat epilepsy and to gradually discontinue use of conventional pharmaceuticals. Another example of cannabinoid mono therapy is the THC pharmaceutical Marinol.
Cannabis Law Report
JULY 21, 2019
Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form. ICC International Cannabis Corp. CSE: WRLD.U)(FWB:
Cannabis Law Report
JULY 19, 2019
Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form.
.png)
Cannabis Law Report
OCTOBER 26, 2019
The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain.
|
|
Cannabis Law Report
SEPTEMBER 14, 2019
Forbes report.
Cannabis Law Report
NOVEMBER 5, 2019
Cabot Wealth Management Inc increased its stake in Gw Pharmaceuticals Plc (GWPH) by 34.2% The institutional investor held 20,865 shares of the major pharmaceuticals company at the end of 2019Q2, valued at $3.60M, up from 15,548 at the end of the previous reported quarter.
Cannabis Law Report
MAY 30, 2019
CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,
Cannabis Law Report
NOVEMBER 23, 2019
for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA® is a project and a registered trademark under the company Green Donation, Ltd. KANNABEIRA and standardised cannabis.
.png)
Cannabis Law Report
JULY 13, 2019
There have been calls to loosen regulations around medical cannabis to increase access for those who need it, but the government must resist and view cannabis with the same scrutiny as any other new medicine. Read all at ( paywall) [link]. Medical Cannabis News
Cannabis Law Report
JUNE 5, 2019
Press Release: Thailand Government Pharmaceutical Organization. Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee. Dr. Vitoon Danwiboon, Director of the Pharmaceutical Organization.
Cannabis Law Report
MAY 29, 2019
Here’s the press release. The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research.
The Fresh Toast
FEBRUARY 8, 2019
can refocus its regulatory approach to pharmaceuticals, adapted from the one used in Europe, to better connect the value prescription drugs provide and their price. Cannabis Medical Marijuana News RX Affordable Care Act Donald Trump drugs FDA Germany health care opioids pharmaceuticals
Nature's Way Medicine
MARCH 3, 2018
Alternative Medicine cannabis education industry Logical Fallacies medical marijuana medicine News Pharmaceuticals Science-Based Medicine Skepticism about cbd dr. roman fake placebo skeptic skeptical skepticism thc truthIt's not easy gathering my wits and going public about this.
The Fresh Toast
OCTOBER 1, 2019
Cannabis Featured Medical Marijuana News autism CBD oil Epilepsy GW Pharmaceuticals Sanjay GuptaLeading marijuana researchers now believe a cannabis compound could treat autism symptoms.
Canna Newswire
JULY 11, 2019
MEDICAL CANNABIS PHARMACEUTICALSTwo Health and Wellness Powerhouses Collaborate to Help Those Suffering from Seizures Through an Innovative and Fast-Acting Intranasal Spray Solution. CHICAGO – July 11, 2019 / Canna Newswire / – Nature’s Grace and Wellness & JC Pharma, Inc.
Medical Marijuana 411
MARCH 18, 2019
Cannabis Science Decriminalization Legalization Medical Marijuana 411 Politics Prohibition Addiction Opioids PharmaceuticalAmerica is in the throes of a major crisis. Opioid addiction has taken over many parts of the country and is taking a number of lives daily. The opioid crisis is at its breaking point right now. More people are spending time in hospitals or losing their lives to opioid overdose than ever before. According to the National Institute on Read Article.
Freedom Leaf
OCTOBER 15, 2018
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.
Project CBD
DECEMBER 5, 2019
Life-threatening side effects from pharmaceuticals led one man to try cannabis. In this testimonial, he shares how cannabis helped him overcome refractory lockjaw and severe nerve pain
Cannabis Law Report
FEBRUARY 26, 2019
Medicinal cannabis was legalised in portugal in June 2018 by Parliament, however only one cannabis-based medication is legal in Portugal; Sativex, produced by British firm GW Pharmaceuticals. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.
Project CBD
NOVEMBER 26, 2018
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.
Project CBD
NOVEMBER 26, 2018
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.
Project CBD
NOVEMBER 26, 2018
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.
Project CBD
OCTOBER 10, 2019
Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials.
Cannabis Life Network
JULY 24, 2019
GW Pharmaceuticals has been creating unusual blends of clinical cannabis for over two decades. Blog Featured Health Marijuana News Science Technology abnormal cbd CBD Epidiolex ethanol gpr GW Pharmaceuticals synthetic cbd
Project CBD
JULY 31, 2018
In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy.
TheAnswerPage
DECEMBER 3, 2019
Has the American Epilepsy Society (AES) published a position statement on the use of CBD for the treatment of seizures? Yes, the AES has.
Project CBD
JULY 31, 2018
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered.
Project CBD
MAY 1, 2019
Conventional pharmaceuticals commonly used to treat pain sometimes have a negative impact on the immune system, GI tract, liver, and kidneys.
52 
Let's personalize your content